Volatility Creates Opportunity, Insights on Price Data – Research on Delta Apparel, Epirus Biopharmaceuticals, Shiloh Industries, and LifeVantage

NEW YORK, NY / ACCESSWIRE / December 1, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Delta Apparel Inc. (NYSE: DLA), Epirus Biopharmaceuticals Inc. (NASDAQ: EPRS), Shiloh Industries Inc. (NASDAQ: SHLO) and LifeVantage Corp (NASDAQ: LFVN). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

DLA Research Package: http://www.traders-choice.com/pdf?s=DLA

EPRS Research Package: http://www.traders-choice.com/pdf?s=EPRS

SHLO Research Package: http://www.traders-choice.com/pdf?s=SHLO

LFVN Research Package: http://www.traders-choice.com/pdf?s=LFVN

============

Highlights from today’s reports include:

On Monday, November 30, 2015, Nasdaq Composite ended at 5,108.67, down 0.37%, Dow Jones Industrial Average declined 0.44%, to finish the day at 17,719.92, and the S&P 500 closed at 2,080.41, down 0.46%.

– Delta Apparel Inc.’s stock increased by 0.53% to close Monday’s session at USD 15.18. The company’s shares fluctuated in the range of USD 15.01 and USD 15.30. A total of 0.01 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.02 million shares and its 52-week average volume of 0.02 million shares. Over the last three days Delta Apparel Inc.’s shares have declined by 2.06% and in the past one week the stock has moved down 2.32%. Furthermore, over the last three months the stock has lost 6.81% while in the past six months the shares have picked up 7.89%. The company has returned 9.60% in the last half year, on a compounded total return basis. Further, the company stock is trading at a price to earnings ratio of 40.80. The stock is trading at a price to book ratio of 0.84, which compares to a historical PB ratio near to 0.50. Additionally, the stock is trading at a price to cash flow ratio of 55.75 and price to sales ratio of 0.27.

– Epirus Biopharmaceuticals Inc.’s stock slipped by 2.60% to close Monday’s session at USD 4.87. The company’s shares oscillated between USD 4.76 and USD 5.00. The stock recorded a trading volume of 0.05 million shares, which was below its 50-day daily average volume of 0.09 million shares and its 52-week average volume of 0.18 million shares. However, over the last five days Epirus Biopharmaceuticals Inc.’s shares have declined by 2.79% and in the past one month the stock has lost 15.01%. In addition, over the last three months the stock has lost 3.56% and year to date the shares have shed 14.11%. The company has given negative returns of 8.97% and 4.51% in the past one month and past one year, respectively, on a compounded total return basis. The company has a market capitalization of USD 118.72 million. The stock is trading at a price to book ratio of 2.41 and price to sales ratio of 413.17.

– Shiloh Industries Inc.’s stock declined 4.72% to close Monday’s session at USD 6.87. The share price vacillated between USD 6.77 and USD 7.37. The stock recorded a trading volume of 0.071 million shares, which was above its 50-day daily average volume of 0.060 million shares and its 52-week average volume of 0.064 million shares. Over the last three days Shiloh Industries Inc.’s shares have declined by 4.18% and in the past one week the stock has moved down 1.86%. Moreover, in the last six months the stock has lost 28.81% and year to date the shares have shed 56.33%. Further, the company stock is trading at a price to earnings ratio of 10.04 and a price to book ratio of 0.85. This compares to a historical PE ratio of 13.07 and a historical PB ratio near to 2.03. Additionally, the stock is trading at a price to cash flow ratio of 2.39 and price to sales ratio of 0.11.

– LifeVantage Corp’s stock remained unchanged to close Monday’s session at USD 8.46. The company’s shares oscillated between USD 8.36 and USD 8.49. The stock recorded a trading volume of 0.09 million shares, which was above its 50-day daily average volume of 0.07 million shares and its 52-week average volume of 0.06 million shares. Over the last three days LifeVantage Corp’s shares have advanced 4.57% and in the past one week the stock has moved up 4.19%. Furthermore, over the last three months the stock has gained 42.18% and in the past six months the shares have picked up 85.93%. On a compounded total return basis, the company has returned 3.93% in the past one week and 9.59% in the past one month. Further, the company is trading at a price to earnings ratio of 35.73, which compares to a historical PE ratio of 7.51.

—

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 434214